<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01248702</url>
  </required_header>
  <id_info>
    <org_study_id>H10-01537</org_study_id>
    <nct_id>NCT01248702</nct_id>
  </id_info>
  <brief_title>A Critical Pathway for Implantable Cardioverter-Defibrillators in Patients With Ischemic Cardiomyopathy</brief_title>
  <acronym>CAPTURE</acronym>
  <official_title>A Critical Pathway for Implantable Cardioverter-Defibrillators in Patients With Ischemic Cardiomyopathy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of British Columbia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of British Columbia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to develop and implement a critical pathway to identify patients
      with ischemic cardiomyopathy who are candidates for an implantable cardioverter-defibrillator
      (ICD). This study will also determine whether the use of the critical pathway for ICDs is
      associated with a change in the ICD referral and implantation rate.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Despite improvements in both medical management and revascularization strategies, sudden
      death is still a significant complication in patients with ischemic cardiomyopathy. There is
      strong evidence to support the role of ICDs for the primary prevention of sudden death in
      this population. However, in Canada and the United States, ICDs are underutilized.

      Critical pathways are algorithms that improve health care delivery and clinical outcomes
      while reducing practice variability. The use of a critical pathway to assess a patient's
      eligibility for an ICD may increase the appropriate use of this evidence-based technology.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>April 2012</start_date>
  <completion_date type="Anticipated">May 2012</completion_date>
  <primary_completion_date type="Anticipated">May 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of Referral for ICD Assessment</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of ICD Implantation</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Myocardial Infarction</condition>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>Critical Pathway</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard Practice</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Use of the ICD Critical Pathway</intervention_name>
    <description>The critical pathway is a series of predetermined processes designed to assess a patient's eligibility for an ICD. The critical pathway will incorporate current evidence-based practice guidelines.</description>
    <arm_group_label>Critical Pathway</arm_group_label>
    <other_name>ICD Critical Pathway</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  acute ST segment elevation myocardial infarction (STEMI)

          -  candidate for percutaneous revascularization

          -  permanent residents of British Columbia, Canada

        Exclusion Criteria:

          -  patients with heart disease or a comorbid illness who have a documented life
             expectancy of less than 1 year
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>S Cowan, MD, MSc</last_name>
    <role>Study Director</role>
    <affiliation>St. Paul's Hospital, Vancouver, British Columbia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>A Ignaszewski, MD</last_name>
    <role>Study Director</role>
    <affiliation>St. Paul's Hospital, Vancouver, British Columbia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>C Kerr, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>St. Paul's Hospital, Vancouver, British Columbia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>S Tung, MD</last_name>
    <role>Study Director</role>
    <affiliation>St. Paul's Hospital, Vancouver, British Columbia</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>S Cowan, MD, MSc</last_name>
    <phone>(604) 682 2344</phone>
    <email>capture.study@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>St. Paul's Hospital</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V6Z 1Y6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>S Cowan, MD, MSc</last_name>
      <phone>(604) 682 2344</phone>
      <email>capture.study@gmail.com</email>
    </contact>
    <investigator>
      <last_name>S Cowan, MD, MSc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>A Ignaszewski, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>C Kerr, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>S Tung, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>March 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 22, 2010</study_first_submitted>
  <study_first_submitted_qc>November 23, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 25, 2010</study_first_posted>
  <last_update_submitted>March 6, 2012</last_update_submitted>
  <last_update_submitted_qc>March 6, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 7, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Myocardial Infarction</keyword>
  <keyword>Heart Failure</keyword>
  <keyword>Sudden Cardiac Death</keyword>
  <keyword>Critical Pathways</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Cardiomyopathies</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

